Search
Gracell Biotechnologies' 2024 Revenue Hits RMB 547 Million, Yet Net Profit Declines 37.68% Year-on-Year
2025-04-21 /
Read about 0 minute
Author：小编
On April 20, Gracell Biotechnologies unveiled its 2024 annual financial report. According to the report, the company's total revenue for the year amounted to RMB 547 million, marking a 14.5% increase from the previous year. However, the net profit attributable to shareholders of the listed company stood at RMB 80.2685 million, experiencing a 37.68% year-on-year decline. Furthermore, the net profit after excluding non-recurring gains and losses was RMB 58.4203 million, reflecting a 46.86% decrease compared to the previous year. Notably, despite these challenges, the company's net cash flow from operating activities witnessed substantial growth, reaching RMB 46.9014 million, an impressive 122.1% year-on-year increase.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
